Vojo Vukovic - 12 Jun 2025 Form 4 Insider Report for DELCATH SYSTEMS, INC. (DCTH)

Reporting relationship: CHIEF MEDICAL OFFICER
Issuer ticker: DCTH
Reported as of: 12 Jun 2025
Net transaction value: +$200,760
SEC form: 4
Accepted by SEC: 13 Jun 2025, 17:22:47 UTC
Prior SEC filing: 07 Feb 2025
Next SEC filing: 18 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ David Hoffman, Attorney-in-Fact

Key filing fact

Vojo Vukovic filed Form 4 for DELCATH SYSTEMS, INC. (DCTH) on 13 Jun 2025.

Key facts

This page summarizes Vojo Vukovic's Form 4 filing for DELCATH SYSTEMS, INC. (DCTH).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 13 Jun 2025, 17:22.

Change

Previous filing in this sequence was filed on 07 Feb 2025.
Current net transaction value: +$200,760.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001466794 Primary reporting owner

Vukovic Vojo

Relationship: CHIEF MEDICAL OFFICER
Address: C/O DELCATH SYSTEMS, INC., 566 QUEENSBURY AVENUE, QUEENSBURY
Signature: /s/ David Hoffman, Attorney-in-Fact
Signature date: 13 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DCTH transaction

Common Stock

Options Exercise

Transaction value: $200,760
Shares: +42,000
Change %: +33%
Price: $4.78
Shares after: 168,882
Date: 12 Jun 2025
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DCTH transaction Derivative

Employee Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -42,000
Change %: -42%
Price: $0.000000
Shares after: 58,500
Date: 12 Jun 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 42,000
Exercise price: $4.78
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option will vest and become exercisable at the rate of one-thirty-sixth (1/36th) per month with the first such vesting to occur on February 12, 2024 and monthly thereafter for so long as the reporting person remains an employee of Delcath Systems, Inc. (and subject to the terms and conditions of the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan, as amended).